News - Page 147 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psychedelic Research Bulletin: July & August 2021

Psychedelic Research Bulletin: July & August 2021

Post published:September 28, 2021
Post category:Psychedelics Research Review

Read more about the article BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

Post published:September 27, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders

Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders

Post published:September 27, 2021
Post category:Press Release

Read more about the article Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre

Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre

Post published:September 27, 2021
Post category:News

Read more about the article MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy

MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy

Post published:September 27, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

Post published:September 24, 2021
Post category:Psychedelic Bulletin

Read more about the article PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

Post published:September 24, 2021
Post category:Press Release

Read more about the article Levitee Labs Announces DTC Eligibility Approval

Levitee Labs Announces DTC Eligibility Approval

Post published:September 24, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London

Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London

Post published:September 23, 2021
Post category:Press Release

Read more about the article Numinus Completes Acquisition of Neurology Centre of Toronto

Numinus Completes Acquisition of Neurology Centre of Toronto

Post published:September 23, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.